Andreas Schirbel
Overview
Explore the profile of Andreas Schirbel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
1728
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schloetelburg W, Hartrampf P, Kosmala A, Serfling S, Dreher N, Schirbel A, et al.
Eur J Nucl Med Mol Imaging
. 2024 Jun;
51(12):3643-3650.
PMID: 38896128
Background: In patients affected with adrenocortical carcinoma (ACC), C-X-C motif chemokine receptor 4 (CXCR4) is highly expressed in sites of disease in an ex-vivo setting. We aimed to determine the...
2.
Schlotelburg W, Hartrampf P, Kosmala A, Fuss C, Serfling S, Buck A, et al.
Endocrine
. 2024 Feb;
84(3):1172-1181.
PMID: 38381353
Purpose: We aimed to evaluate the prognostic potential of baseline [F]FDG PET/CT for overall survival (OS) in patients with adrenocortical carcinoma (ACC). Methods: We performed a retrospective analysis of 67...
3.
Hahner S, Higuchi T, Serfling S, Samnick S, Fuss C, Heinze B, et al.
Clin Nucl Med
. 2024 Feb;
49(4):369-370.
PMID: 38350087
We report on an adrenocortical carcinoma (ACC) patient, which has exhausted previous treatment options and was scheduled for prostate-specific membrane antigen (PSMA)- and C-X-C motif chemokine receptor 4 (CXCR4)-targeted PET/CT....
4.
Michalski K, Schlotelburg W, Hartrampf P, Kosmala A, Buck A, Hahner S, et al.
Pharmaceuticals (Basel)
. 2024 Jan;
17(1).
PMID: 38256859
Adrenocortical carcinoma (ACC) represents a rare tumor entity with limited treatment options and usually rapid tumor progression in case of metastatic disease. As further treatment options are needed and ACC...
5.
Dreher N, Hahner S, Fuss C, Schlotelburg W, Hartrampf P, Serfling S, et al.
Eur J Nucl Med Mol Imaging
. 2023 Dec;
51(5):1383-1394.
PMID: 38082196
Background: C-X-C motif chemokine receptor 4 (CXCR4) is overexpressed in various solid cancers and can be targeted by CXCR4-directed molecular imaging. We aimed to characterize the in-vivo CXCR4 expression in...
6.
Zhi Y, Werner R, Schirbel A, Higuchi T, Buck A, Kosmala A, et al.
Am J Nucl Med Mol Imaging
. 2023 Nov;
13(5):208-216.
PMID: 38023816
Background: The aim of this study was to determine the read-out capabilities of the novel C-X-C motif chemokine receptor 4 (CXCR4)-targeting radiotracer [Ga]Ga-PentixaFor compared to the reference radiotracer [F]FDG in...
7.
Maier P, Heinze B, Gabor S, Reese S, Hahner S, Schirbel A
Bioorg Med Chem Lett
. 2023 Oct;
96:129501.
PMID: 37804995
The enzyme aldosterone synthase (CYP11B2) is specifically expressed in aldosterone-producing tissue of the adrenal cortex and is overexpressed in aldosterone-producing adenomas (APA). It therefore represents an ideal target for molecular...
8.
Cytawa W, Hendel R, Tomasik B, Weinzierl F, Bley T, Jassem J, et al.
Eur J Nucl Med Mol Imaging
. 2023 Jul;
50(12):3765-3776.
PMID: 37474735
Purpose: The aim of this study was to investigate very early radiographic PSMA PET response after one cycle of [Lu]Lu-PSMA I&T radioligand therapy (RLT) of metastatic castration-resistant prostate cancer (mCRPC)...
9.
Hartlapp I, Hartrampf P, Serfling S, Wild V, Weich A, Rasche L, et al.
J Nucl Med
. 2023 Jun;
64(9):1424-1430.
PMID: 37348915
Desmoplastic small round cell tumor (DSRCT) is a rare, radiosensitive, yet difficult-to-treat sarcoma subtype affecting predominantly male adolescents. Extensive intraperitoneal seeding is common and requires multimodal management. With no standard...
10.
Weich A, Serfling S, Schlotelburg W, Higuchi T, Hartrampf P, Schirbel A, et al.
Clin Nucl Med
. 2023 May;
48(7):586-593.
PMID: 37167408
Purpose: To elucidate the influence of CXC motif chemokine receptor 4 (CXCR4)-directed imaging on staging and proposed oncologic management in patients with digestive system tumors compared with guideline-appropriate imaging (GAI)....